Company Filing History:
Years Active: 1999-2002
Title: Inventor Spotlight: Stefan Muellner
Introduction
Stefan Muellner, a prominent inventor based in Hochheim, Germany, has made significant contributions to the field of molecular biology. With a total of three patents to his name, he has played a pivotal role in the identification and characterization of novel DEAH-box proteins, which are essential for various biochemical applications.
Latest Patents
Among his latest innovations are two patents focused on DEAH-box proteins. These patents detail the identification and molecular-biological characterization of these proteins, which share structural similarities with other known helicases. The inventions describe DNA sequences encoding these proteins, demonstrating their ability to bind ATP and nucleic acids while possessing helicase and ATPase activities. Furthermore, these patents outline processes for preparing such proteins and their applications in pharmacologically relevant test systems and therapeutic uses.
Career Highlights
Stefan Muellner has built a noteworthy career through his work at Aventis Research & Technologies GmbH & Co. KG. His expertise and innovative approach have contributed to advancements in research and development, particularly within molecular biology and biochemistry.
Collaborations
Throughout his career, Muellner has collaborated with esteemed colleagues, including Bernd Kirschbaum and Robert R. Bartlett. These partnerships have undoubtedly enhanced the research outputs and fostered an environment of innovation in their field.
Conclusion
Stefan Muellner's contributions to science through his patents on DEAH-box proteins highlight his role as a leading inventor. His work not only showcases the potential of these proteins in therapeutic applications but also underscores the importance of collaboration in advancing scientific research.